Brighton Jones LLC acquired a new stake in Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 6,878 shares of the company’s stock, valued at approximately $203,000. Several other large investors also recently bought […]